Nashville, Tenn.-based Vanderbilt University Medical Center will implement an AI-based clinical analytics platform from software company Nference to expand clinical insights in research areas.
The platform will provide Vanderbilt researchers with diverse datasets and aims to advance insights for drug discovery and patient care, according to a July 25 press release from Vanderbilt.
"Nference's advanced capability to utilize information gathered from electronic health records, imaging data, and digital pathology data, when combined with our historic and deep experience and leadership in biomedical informatics and health information technology, allows us to advance the understanding of devastating diseases while accelerating biomedical research," said Jeff Balser, MD, PhD, president and CEO of Vanderbilt University Medical Center.
Nference's AI-enabled clinical analytics platform, dubbed nSights, provides datasets for therapeutic areas such as cardiology, immunology and rare diseases.